Eugene A. Mash

Bright blue organic light-emitting diode with improved color purity using a LiF/Al cathode

We report a two-layer, blue organic light-emitting diode with a 4,4′-bis(2,2-diphenylvinyl)-1,1′-biphenyl emission layer and a LiF/Al cathode which has an external quantum efficiency of 1.4% and a maximum luminance of 3000 cd/m2. Insertion of the thin LiF layer results in a 50-fold increase in the device efficiency compared to a device with an aluminum only cathode, and eliminates the need for an electron-transporting layer, such as tris(8-hydroxyquinoline)aluminum. This results in a device with excellent color purity with an emission peak at 476 nm and a full width at half maximum of 78 nm. Using ultraviolet photoelectron spectroscopy, we find that the effective work-function of aluminum decreases dramatically with sub-monolayer amounts of LiF deposited on the surface.

Energy and charge transfer in organic light-emitting diodes: A soluble quinacridone study

A soluble derivative of quinacridone, N,N′-di-isoamyl quinacridone (DIQA), has been synthesized and used to study the mechanisms of Forster energy transfer and charge transfer in organic light-emitting diodes (OLEDs) based on 8-hydroxyquinoline (Alq3). Quantum efficiencies and spectra were measured for both photoluminescence (PL) and electroluminescence (EL) for films of poly(9-vinylcarbazole) (PVK) doped with Alq3 and DIQA. Both PL and EL showed an efficiency enhancement in films of PVK:Alq3:DIQA compared to films of PVK:Alq3. However, the optimal DIQA doping concentration was found to be lower for EL than for PL. Examination of the spectra revealed that more emission originated from DIQA for EL than for PL at a given doping level. We conclude that Forster energy transfer from Alq3 to DIQA occurs in both cases of PL and EL, but that charge transfer to DIQA occurs in the operation of the OLED resulting in additional pathways to DIQA emission. Ultraviolet photoelectron spectroscopy measurements showed that...

Deoxycholic Acid Induces Intracellular Signaling through Membrane Perturbations

Secondary bile acids have long been postulated to be tumor promoters in the colon; however, their mechanism of action remains unclear. In this study, we examined the actions of bile acids at the cell membrane and found that they can perturb membrane structure by alteration of membrane microdomains. Depletion of membrane cholesterol by treating with methyl-β-cyclodextrin suppressed deoxycholic acid (DCA)-induced apoptosis, and staining for cholesterol with filipin showed that DCA caused a marked rearrangement of this lipid in the membrane. Likewise, DCA was found to affect membrane distribution of caveolin-1, a marker protein that is enriched in caveolae membrane microdomains. Additionally, fluorescence anisotropy revealed that DCA causes a decrease in membrane fluidity consistent with the increase in membrane cholesterol content observed after 4 h of DCA treatment of HCT116 cells. Significantly, by using radiolabeled bile acids, we found that bile acids are able to interact with and localize to microdomains differently depending on their physicochemical properties. DCA was also found to induce tyrosine phosphorylation and activate the receptor tyrosine kinase epidermal growth factor receptor in a ligand-independent manner. In contrast, ursodeoxycholic acid did not exhibit any of these effects even though it interacted significantly with the microdomains. Collectively, these data suggest that bile acid-induced signaling is initiated through alterations of the plasma membrane structure and the redistribution of cholesterol.

Hitting multiple targets with multimeric ligands.

Multimeric ligands consist of multiple monomeric ligands attached to a single backbone molecule, creating a multimer that can bind to multiple receptors or targets simultaneously. Numerous examples of multimeric binding exist within nature. Due to the multiple and simultaneous binding events, multimeric ligands bind with an increased affinity compared to their corresponding monomers. Multimeric ligands may provide opportunities in the field of drug discovery by providing enhanced selectivity and affinity of binding interactions, thus providing molecular-based targeted therapies. However, gaps in our knowledge currently exist regarding the quantitative measures for important design characteristics, such as flexibility, length and orientation of the inter-ligand linkers, receptor density and ligand sequence. In this review, multimeric ligand binding in two separate phases is examined. The prerecruitment phase describes the binding of one ligand of a multimer to its corresponding receptor, an event similar to monomeric ligand binding. This results in transient increases in the local concentration of the other ligands, leading to apparent cooperativity. The postrecruitment phase only occurs once all receptors have been aligned and bound by their corresponding ligand. This phase is analogous to DNA–DNA interactions in that the stability of the complex is derived from physical orientation. Multiple factors influence the kinetics and thermodynamics of multimeric binding, and these are discussed.

Whispering-gallery-mode microring laser using a conjugated polymer

We observed laser emission in whispering gallery modes using a microring composed of a semiconducting polymer poly[2,5-bis-(2′-ethylhexyloxy)-p-phenylenevinylene coated on an etched fiber under transient and quasisteady-state pumping conditions. The threshold for laser oscillation was 1 mJ/cm2 (0.1 MW/cm2) and 30 μJ/cm2 (300 MW/cm2) for nanosecond and femtosecond excitation, respectively. The laser output showed superlinear dependence on the excitation energy above the threshold. The demonstration of lasing under quasisteady-state pumping shows the possibility to develop electrically pumped polymer lasers.

Heterobivalent Ligands Crosslink Multiple Cell-Surface Receptors: The Human Melanocortin-4 and δ-Opioid Receptors†

Cell-surface receptor mediated signaling is mechanistically complex. Hetero- and homo-multimerization of receptors appears to occur naturally and is a significant regulatory component of signal transduction.[1] Additionally, exogenous entities, such as cells and viruses, can interact with multiple heterologous receptors and induce clustering.[2] Such multivalent interactions are characterized by enhanced affinities (avidities) relative to monovalent binding and enhanced specificities with heteromultivalent interactions. For example, polymers containing α-MSH (α-melanocyte stimulating hormone) ligands bind with higher affinity to melanoma cells compared to monovalent α-MSH ligands.[3–5] Recapitulation of these natural phenomena using synthetic multivalent agents has been proposed for many years.[3–9] Although homomultivalent agents are known, there is little precedent for synthetic heteromultivalent targeting of cell-surface receptors. Herein we detail the synthesis and bioevaluation of heterobivalent ligands (htBVLs) targeted to two heterologous cell-surface receptors.

Discovery of a novel class of AKT pleckstrin homology domain inhibitors

AKT, a phospholipid-binding serine/threonine kinase, is a key component of the phosphoinositide 3-kinase cell survival signaling pathway that is aberrantly activated in many human cancers. Many attempts have been made to inhibit AKT; however, selectivity remains to be achieved. We have developed a novel strategy to inhibit AKT by targeting the pleckstrin homology (PH) domain. Using in silico library screening and interactive molecular docking, we have identified a novel class of non–lipid-based compounds that bind selectively to the PH domain of AKT, with “in silico” calculated KD values ranging from 0.8 to 3.0 μmol/L. In order to determine the selectivity of these compounds for AKT, we used surface plasmon resonance to measure the binding characteristics of the compounds to the PH domains of AKT1, insulin receptor substrate-1, and 3-phosphoinositide–dependent protein kinase 1. There was excellent correlation between predicted in silico and measured in vitro KDs for binding to the PH domain of AKT, which were in the range 0.4 to 3.6 μmol/L. Some of the compounds exhibited PH domain–binding selectivity for AKT compared with insulin receptor substrate-1 and 3-phosphoinositide–dependent protein kinase 1. The compounds also inhibited AKT in cells, induced apoptosis, and inhibited cancer cell proliferation. In vivo, the lead compound failed to achieve the blood concentrations required to inhibit AKT in cells, most likely due to rapid metabolism and elimination, and did not show antitumor activity. These results show that these compounds are the first small molecules selectively targeting the PH domain of AKT. [Mol Cancer Ther 2008;7(9):2621–32]

Photoconductive properties of PVK-based photorefractive polymer composites doped with fluorinated styrene chromophores

We have synthesized nine anisotropic chromophores, with different degrees of fluorination, and studied the effect of the chromophores ionization potential on charge-transfer complexation, photoconductivity, and response time in photorefractive polymer mixtures based on poly(vinylcarbazole). (2,4,7-Trinitrofluoren-9-ylidene)malononitrile (TNFDM) or C 60 provided the sensitization. We have found evidence of strong complexation between TNFDM and the chromophore. At high electric fields, the photoconductivity decays during illumination and reaches a limiting value that correlates with the chromophores ionization potential. A buildup of C 60 – radical anions is observed simultaneously. The strong decline in photoconductivity correlates with an increase in the photorefractive grating buildup time.

Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor

Phosphatidylinositol 3-kinase/phosphatidylinositide-dependent protein kinase 1 (PDPK1)/Akt signaling plays a critical role in activating proliferation and survival pathways within cancer cells. We report the molecular pharmacology and antitumor activity of PHT-427, a compound designed to bind to the pleckstrin homology (PH) binding domain of signaling molecules important in cancer. Although originally designed to bind the PH domain of Akt, we now report that PHT-427 also binds to the PH domain of PDPK1. A series of PHT-427 analogues with variable C-4 to C-16 alkyl chain length were synthesized and tested. PHT-427 itself (C-12 chain) bound with the highest affinity to the PH domains of both PDPK1 and Akt. PHT-427 inhibited Akt and PDPK1 signaling and their downstream targets in sensitive but not resistant cells and tumor xenografts. When given orally, PHT-427 inhibited the growth of human tumor xenografts in immunodeficient mice, with up to 80% inhibition in the most sensitive tumors, and showed greater activity than analogues with C4, C6, or C8 alkyl chains. Inhibition of PDPK1 was more closely correlated to antitumor activity than Akt inhibition. Tumors with PIK3CA mutation were the most sensitive, and K-Ras mutant tumors were the least sensitive. Combination studies showed that PHT-427 has greater than additive antitumor activity with paclitaxel in breast cancer and with erlotinib in non–small cell lung cancer. When given >5 days, PHT-427 caused no weight loss or change in blood chemistry. Thus, we report a novel PH domain binding inhibitor of PDPK1/Akt signaling with significant in vivo antitumor activity and minimal toxicity. Mol Cancer Ther; 9(3); 706–17

Homochiral ketals in organic synthesis. Diastereoselective cyclopropanation of α,β-unsaturated ketals derived from 1,4-D1-O-benzyl-l-threitol

Abstract 2-Cycloalken-1-one 1,4-di - O -benzyl -L-threitol ketals undergo efficient and diastereoselective cyclopropanation when treated with an excess of the Simmons-Smith reagent. For example, 2-cyclohexen-1-one 1,4-di - O -benzyl -L-threitol ketal gave in 90-98% yield a 9:1 mixture of diastereomeric cyclopropanes as established by 62.9 MHz 13C NMR spectroscopy and by hydrolysis of the mixture to (1 R ,6 S )-bicyclo[4.1.0] heptan-2-one. Sixteen other examples are presented which demonstrate the generality and predictability of the process for 2-cycloalken-1-one ketals, as wall as an unfortunate lack of diastereoselectivity for α,β-unsaturated 1,4-di- O -benzyl-L-threitol acetals.